NCT07025330 A Study of Efgartigimod in Patients With IgG4-Related Disease Status RECRUITING Phase PHASE2
NCT06497387 Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease Status RECRUITING Phase EARLY_PHASE1
NCT06497361 Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease Status RECRUITING Phase EARLY_PHASE1
NCT06285539 Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases Status RECRUITING Phase PHASE2
NCT03690908 Infraorbital Nerve Involvement on Magnetic Resonance Imaging in IgG4-related Ophthalmic Disease Status COMPLETED Phase N/A
NCT03368274 To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom Status UNKNOWN Phase PHASE4
NCT03267875 A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood Status UNKNOWN Phase NA
NCT02899039 Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease Status COMPLETED Phase NA
NCT02705638 Treatment of IgG4-Related Disease With Revlimid and Rituximab Status COMPLETED Phase PHASE1
NCT02616705 Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis Status COMPLETED Phase N/A